Condition
Non-cystic Fibrosis Bronchiectasis clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Non-cystic Fibrosis Bronchiectasis clinical trials that are recruiting, at sites in 13 countries (most in United States (4), Egypt (3), United Kingdom (2)). By phase: Phase 2 (3), Phase 4 (2), Phase 3 (2). The most active sponsors are Assiut University (3), Haisco Pharmaceutical Group Co., Ltd. (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 13Countries
Newest Non-cystic Fibrosis Bronchiectasis clinical trials
All recruiting trials (11)
-
Galvokimig vs placebo for non-CF bronchiectasis in adults
This study tests whether Galvokimig can delay the first pulmonary flare compared with placebo in adults with non-CF bronchiectasis.
-
Safety test of HSK31858 in people with non-cystic fibrosis bronchiectasis
This phase 3 study tests whether HSK31858 is safe for adults with non-cystic fibrosis bronchiectasis who previously participated in the related study.
-
Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups
This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.
-
Bronchiectasis Phenotype Identification Model for Adults
This study tests a baseline classifier to categorize adults with non-cystic fibrosis bronchiectasis into phenotype groups using data collected over time.
-
BASE: Aiming to test a simple, objective way to gauge bronchiectasis severity and predict flare-ups
This study tests a new BASE framework to classify how severe non-cystic fibrosis bronchiectasis is right now and see if it can predict 12 months of worsening or flare-ups.
-
Nebulized CSL787 (inhaled IgG) to reduce lung flare-ups in adults with non-cystic fibrosis bronchiectasis
This research will test whether inhaled CSL787 (a nebulized immunoglobulin medicine) can delay or reduce lung flare-ups in adults with non-cystic fibrosis bronchiectasis over 6–12 months compared with placebo.
-
Assessing a new treatment for non-cystic fibrosis bronchiectasis
This study is testing a new treatment called HSK31858 to see if it can help people with non-cystic fibrosis bronchiectasis feel better and have fewer flare-ups.
-
Testing Ensifentrine for Non-Cystic Fibrosis Bronchiectasis
This study tests if a new inhaled medication called ensifentrine can help people with non-cystic fibrosis bronchiectasis feel better and have fewer lung problems compared to standard treatment.
-
Evaluation of the SIMEOX Device for Bronchiectasis Management at Home
This study is testing if using the SIMEOX device along with remote physiotherapy can help people with bronchiectasis feel better and have fewer breathing problems compared to standard care.
-
Using hypertonic saline to improve mucus clearance in bronchiectasis
This study is testing if a special salt solution delivered through a nebulizer can help adults with bronchiectasis clear mucus from their lungs better.
-
Breathing training program for improving exercise capacity in patients with non-cystic fibrosis bronchiectasis
This study is testing if a home breathing training program can help people with non-cystic fibrosis bronchiectasis exercise better and improve their lung function.
Related topics
Quick answers
How many Non-cystic Fibrosis Bronchiectasis clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (4 trials), Egypt (3 trials), United Kingdom (2 trials), China (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.